These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 9012556)

  • 1. Dose-response of inhaled drugs in asthma. An update.
    Clark DJ; Lipworth BJ
    Clin Pharmacokinet; 1997 Jan; 32(1):58-74. PubMed ID: 9012556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting beta-agonists and their association with inhaled corticosteroids in COPD.
    Fuso L; Mores N; Valente S; Malerba M; Montuschi P
    Curr Med Chem; 2013; 20(12):1477-95. PubMed ID: 23409722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of corticosteroids in bronchial asthma.
    Lipworth BJ
    Pharmacol Ther; 1993; 58(2):173-209. PubMed ID: 8415878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.
    Grove A; Lipworth BJ
    Thorax; 1996 Jun; 51(6):585-9. PubMed ID: 8693438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?
    Holimon TD; Chafin CC; Self TH
    Drugs; 2001; 61(3):391-418. PubMed ID: 11293649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma.
    Bartow RA; Brogden RN
    Drugs; 1998 Feb; 55(2):303-22. PubMed ID: 9506248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies involving inhaled beta-agonists and inhaled corticosteroids in the treatment of asthma.
    Fahy JV; Boushey HA
    Clin Chest Med; 1995 Dec; 16(4):715-33. PubMed ID: 8565410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients.
    Lipworth BJ; Newnham DM; Clark RA; Dhillon DP; Winter JH; McDevitt DG
    Thorax; 1995 Jan; 50(1):54-61. PubMed ID: 7886650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled beta 2-adrenoceptor agonists in asthma: help or hindrance?
    Lipworth BJ; McDevitt DG
    Br J Clin Pharmacol; 1992 Feb; 33(2):129-38. PubMed ID: 1347999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
    JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant inhaled corticosteroid resensitises cardiac beta2-adrenoceptors in the presence of long-acting beta2-agonist therapy.
    Aziz I; McFarlane LC; Lipworth BJ
    Eur J Clin Pharmacol; 1998 Jul; 54(5):377-81. PubMed ID: 9754979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing a variable disease.
    Kips J
    Pulm Pharmacol Ther; 2002; 15(6):485-90. PubMed ID: 12493334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of salmeterol.
    Cazzola M; Testi R; Matera MG
    Clin Pharmacokinet; 2002; 41(1):19-30. PubMed ID: 11825095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic optimisation of asthma treatment.
    Taburet AM; Schmit B
    Clin Pharmacokinet; 1994 May; 26(5):396-418. PubMed ID: 7914480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salmeterol: a novel, long-acting beta 2-agonist.
    Meyer JM; Wenzel CL; Kradjan WA
    Ann Pharmacother; 1993 Dec; 27(12):1478-87. PubMed ID: 7905757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guideline for the management of chronic asthma in children--2000 update. Allergy Society of South Africa Working Group.
    Motala C; Kling S; Gie R; Potter PC; Manjra A; Vermeulen J; Weinberg EG; Green R
    S Afr Med J; 2000 May; 90(5 Pt 2):524-8, 530, 532 passim. PubMed ID: 10901828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE; Noonan MJ
    J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of childhood asthma: how do the available options compare?
    Coghlan D; Powell C
    Paediatr Drugs; 2003; 5(10):685-98. PubMed ID: 14510626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy and safety of inhaled corticosteroids in asthma.
    Jackson LD; Polygenis D; McIvor RA; Worthington I
    Can J Clin Pharmacol; 1999; 6(1):26-37. PubMed ID: 10465863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.